$CVM
CEL SCI CORP Stock $cvm

$cvm Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000165495423010485 Filed on August 10, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.200M	$2.454M	$2.487M
YoY Change	-11.53%	0.88%	-21.88%
% of Gross Profit
Research & Development	$5.268M	$5.728M	$6.461M
YoY Change	-18.48%	-8.89%	22.13%
% of Gross Profit
Depreciation & Amortization	$998.7K	$985.7K	$982.9K
YoY Change	1.6%	0.71%	69.06%
% of Gross Profit
Operating Expenses	$7.468M	$8.182M	$8.948M
YoY Change	-16.55%	-6.17%	5.6%
Operating Profit		-$8.182M
YoY Change		-6.17%
Interest Expense	-$181.9K	-$181.7K	$379.0K
YoY Change	-147.99%	-80.11%	1807.5%
% of Operating Profit
Other Income/Expense, Net	$18.71K	-$3.850K	$107.2K
YoY Change	-82.54%		-56.95%
Pretax Income	-$7.631M	-$8.367M	-$8.462M
YoY Change	-9.82%	-13.14%	3.13%
Income Tax
% Of Pretax Income
Net Earnings	-$7.631M	-$8.367M	-$8.462M
YoY Change	-9.82%	-13.14%	3.13%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.16	-$0.19	-$195.8K
COMMON SHARES
Basic Shares Outstanding	47.26M shares	44.71M shares	43.37M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.150M	$5.159M	$22.67M
YoY Change	-81.7%	-81.62%	-46.29%
Cash & Equivalents	$4.146M	$5.135M	$22.67M
Short-Term Investments	$4.250K	$23.85K	$0.00
Other Short-Term Assets	$520.4K	$462.9K	$762.1K
YoY Change	-31.72%	-34.68%	-23.68%
Inventory	$2.248M	$2.110M	$2.002M
Prepaid Expenses	$520.4K	$462.8K	$762.1K
Receivables			$0.00
Other Receivables			$0.00
Total Short-Term Assets	$6.918M	$7.732M	$25.44M
YoY Change	-72.8%	-75.02%	-43.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.19M	$10.67M	$11.89M
YoY Change	-14.31%	-13.87%	-12.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.394M	$2.400M	$164.3K
YoY Change	1356.95%		-91.4%
Total Long-Term Assets	$23.61M	$24.59M	$25.09M
YoY Change	-5.89%	-5.19%	-18.01%
TOTAL ASSETS
Total Short-Term Assets	$6.918M	$7.732M	$25.44M
Total Long-Term Assets	$23.61M	$24.59M	$25.09M
Total Assets	$30.53M	$32.32M	$50.52M
YoY Change	-39.58%	-43.19%	-33.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.010M	$1.743M	$1.618M
YoY Change	24.19%	104.33%	-3.43%
Accrued Expenses	$1.050M	$1.141M	$842.5K
YoY Change	24.58%	14.94%	-1.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.772M	$1.718M	$1.600M
YoY Change	10.74%	14.54%	166.67%
Total Short-Term Liabilities	$5.586M	$5.292M	$4.664M
YoY Change	19.77%	31.8%	18.46%
LONG-TERM LIABILITIES
Long-Term Debt	$9.950M	$10.41M	$11.72M
YoY Change	-15.12%	-14.17%	-11.55%
Other Long-Term Liabilities	$125.0K	$125.0K	$125.0K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$125.0K	$125.0K	$125.0K
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.586M	$5.292M	$4.664M
Total Long-Term Liabilities	$125.0K	$125.0K	$125.0K
Total Liabilities	$17.31M	$17.53M	$18.36M
YoY Change	-5.7%	-3.48%	-5.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$487.1M	-$479.5M	-$454.9M
YoY Change	7.08%	7.4%	8.78%
Common Stock	$474.2K	$447.5K	$434.5K
YoY Change	9.15%	3.21%	0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.21M	$14.79M	$32.16M
YoY Change
Total Liabilities & Shareholders Equity	$30.53M	$32.32M	$50.52M
YoY Change	-39.58%	-43.19%	-33.41%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q3
OPERATING ACTIVITIES
Net Income	-$7.631M	-$8.367M	-$8.462M
YoY Change	-9.82%	-13.14%	3.13%
Depreciation, Depletion And Amortization	$998.7K	$985.7K	$982.9K
YoY Change	1.6%	0.71%	69.06%
Cash From Operating Activities	-$5.045M	-$5.666M	-$4.914M
YoY Change	2.67%	-2.14%	2.32%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$196.9K	-$16.06K
YoY Change	-100.0%	-377.38%	-95.86%
Acquisitions
YoY Change
Other Investing Activities	-$10.37K	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$10.37K	-$196.9K	-$16.06K
YoY Change	-35.43%	177.38%	-100.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.066M	951.6K	-471.8K
YoY Change	-961.85%	-372.96%	-249.79%
NET CHANGE
Cash From Operating Activities	-5.045M	-5.666M	-4.914M
Cash From Investing Activities	-10.37K	-196.9K	-16.06K
Cash From Financing Activities	4.066M	951.6K	-471.8K
Net Change In Cash	-989.3K	-4.911M	-5.402M
YoY Change	-81.68%	-20.9%	-5372.87%
FREE CASH FLOW
Cash From Operating Activities	-$5.045M	-$5.666M	-$4.914M
Capital Expenditures	$0.00	$196.9K	-$16.06K
Free Cash Flow	-$5.045M	-$5.863M	-$4.898M
YoY Change	3.0%	2.52%	10.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000725363
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44748437	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43448317	shares
CY2022Q2	cvm	Incremental Cost Deemed Dividend IncrementalCostDeemedDividend	294000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000.0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-11889
	dei	Entity Registrant Name EntityRegistrantName	CEL-SCI CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-0916344
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8229 Boone Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 802
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vienna
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22182
	dei	City Area Code CityAreaCode	703
	dei	Local Phone Number LocalPhoneNumber	506-9460
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CVM
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47260097	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5135070	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22672138	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	462848	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	762063	usd
CY2023Q2	cvm	Supplies Used For Rd And Manufacturing Current SuppliesUsedForRDAndManufacturingCurrent	2109978	usd
CY2022Q3	cvm	Supplies Used For Rd And Manufacturing Current SuppliesUsedForRDAndManufacturingCurrent	2001715	usd
CY2023Q2	cvm	Deposit Assets Current DepositAssetsCurrent	23850	usd
CY2022Q3	cvm	Deposit Assets Current DepositAssetsCurrent	0	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	7731746	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	25435916	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9583440	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10937797	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1746355	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1884464	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10674725	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11889029	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	183074	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212201	usd
CY2023Q2	us-gaap	Deposits Assets DepositsAssets	2319101	usd
CY2022Q3	us-gaap	Deposits Assets DepositsAssets	0	usd
CY2023Q2	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	80527	usd
CY2022Q3	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	164299	usd
CY2023Q2	us-gaap	Assets Assets	32318968	usd
CY2022Q3	us-gaap	Assets Assets	50523706	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1742651	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1618290	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1141292	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	842492	usd
CY2023Q2	cvm	Due To Employee Current DueToEmployeeCurrent	499661	usd
CY2022Q3	cvm	Due To Employee Current DueToEmployeeCurrent	471488	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1718038	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1560553	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	190831	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170928	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5292473	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4663751	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	10406939	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	11721368	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1705157	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1850380	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	17529569	usd
CY2022Q3	us-gaap	Liabilities Liabilities	18360499	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	447484	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	434484	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	493802607	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	486625816	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-479460692	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-454897093	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	14789399	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32163207	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32318968	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50523706	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17203823	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18893857	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6804729	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8220768	usd
	us-gaap	Operating Expenses OperatingExpenses	24008552	usd
	us-gaap	Operating Expenses OperatingExpenses	27114625	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24008552	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27114625	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	366791	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-30793	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-493522	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1460055	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	61525	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24563599	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28238682	usd
	cvm	Modification Of Warrants ModificationOfWarrants	-171552	usd
	cvm	Modification Of Warrants ModificationOfWarrants	-294409	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24735151	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28533091	usd
	cvm	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.57
	cvm	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.66
	cvm	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	43761395	shares
	cvm	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	43124972	shares
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5727789	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6286873	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2453968	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2432518	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	8181757	usd
CY2022Q2	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	2447772	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	57208	usd
CY2022Q2	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	122266	usd
CY2022Q2	cvm	Warrants Modification Adjustments WarrantsModificationAdjustments	634713	usd
CY2022Q2	cvm	Share Issuance Costs ShareIssuanceCosts	-28560	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9632584	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	8719391	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8181757	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8719391	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-181670	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-913193	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3854	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8367281	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9632584	usd
CY2023Q2	cvm	Modification Of Warrants ModificationOfWarrants	0	usd
CY2022Q2	cvm	Modification Of Warrants ModificationOfWarrants	-294409	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8367281	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9926993	usd
CY2023Q2	cvm	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.19
CY2022Q2	cvm	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.23
CY2023Q2	cvm	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	44254363	shares
CY2022Q2	cvm	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	43174775	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32163207	usd
CY2022Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	447291	usd
CY2022Q4	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	1703931	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	50178	usd
CY2022Q4	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	91623	usd
CY2022Q4	cvm	Incentive Stock Forfeited Amount IncentiveStockForfeitedAmount	-11100	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7853509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26591621	usd
CY2023Q1	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	1743288	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	54865	usd
CY2023Q1	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	100635	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8342809	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20147600	usd
CY2023Q2	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	1551319	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	52663	usd
CY2023Q2	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	135669	usd
CY2023Q2	cvm	Proceeds From The Sale Of Common Stock Amount ProceedsFromTheSaleOfCommonStockAmount	1391897	usd
CY2023Q2	cvm	Incentive Stock Forfeited Amount IncentiveStockForfeitedAmount	-11100	usd
CY2023Q2	cvm	Share Issuance Costs ShareIssuanceCosts	-111368	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8367281	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	14789399	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	56534226	usd
CY2021Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	157954	usd
CY2021Q4	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	3262296	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	52555	usd
CY2021Q4	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	143160	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	29835	usd
CY2021Q4	cvm	Share Issuance Costs ShareIssuanceCosts	-45965	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-8782606	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	51351455	usd
CY2022Q1	cvm	Warrant Exercises Amount WarrantExercisesAmount	13860	usd
CY2022Q1	cvm	Equity Based Compensation Employees EquityBasedCompensationEmployees	3392706	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	57517	usd
CY2022Q1	cvm	Stock And Options Issued To Nonemployees For Service Amount StockAndOptionsIssuedToNonemployeesForServiceAmount	140052	usd
CY2022Q1	cvm	Share Issuance Costs ShareIssuanceCosts	-4550	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9823492	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45127548	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	38728363	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24563599	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28238682	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2959681	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2845978	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	12788	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	49390	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	473723	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	603147	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4976338	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9102774	usd
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	157706	usd
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	167280	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	615	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	30793	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	366791	usd
	cvm	Warrants Modification Adjustments WarrantsModificationAdjustments	0	usd
	cvm	Warrants Modification Adjustments WarrantsModificationAdjustments	634713	usd
	cvm	Loss On Receivables LossOnReceivables	0	usd
	cvm	Loss On Receivables LossOnReceivables	54922	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-208419	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-147192	usd
	cvm	Increase Decrease In Supplies Used For Rd And Manufacturing IncreaseDecreaseInSuppliesUsedForRDAndManufacturing	24491	usd
	cvm	Increase Decrease In Supplies Used For Rd And Manufacturing IncreaseDecreaseInSuppliesUsedForRDAndManufacturing	166453	usd
	cvm	Increase Decrease In Deposit Assets IncreaseDecreaseInDepositAssets	2342951	usd
	cvm	Increase Decrease In Deposit Assets IncreaseDecreaseInDepositAssets	-1910917	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	66616	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-410536	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	243800	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78729	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	28173	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	230012	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17803797	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13327230	usd
	cvm	Proceeds From Maturity Of Us Treasury Bills ProceedsFromMaturityOfUsTreasuryBills	0	usd
	cvm	Proceeds From Maturity Of Us Treasury Bills ProceedsFromMaturityOfUsTreasuryBills	6152000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361892	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	621826	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22741	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-361892	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5507433	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1391897	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	53196	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	50515	usd
	cvm	Proceeds From Exercises Of Warrants And Options ProceedsFromExercisesOfWarrantsAndOptions	447291	usd
	cvm	Proceeds From Exercises Of Warrants And Options ProceedsFromExercisesOfWarrantsAndOptions	101225	usd
	cvm	Proceeds From The Exercises Of Stock Options ProceedsFromTheExercisesOfStockOptions	0	usd
	cvm	Proceeds From The Exercises Of Stock Options ProceedsFromTheExercisesOfStockOptions	29835	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	786454	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	1157371	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	1033677	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	628621	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-166678	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17537068	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7986475	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22672138	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36060148	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5135070	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28073673	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16268	usd
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	927	usd
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	1800	usd
	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	327927	usd
	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	221242	usd
	cvm	Exercise Of Derivative Liabilities ExerciseOfDerivativeLiabilities	0	usd
	cvm	Exercise Of Derivative Liabilities ExerciseOfDerivativeLiabilities	70589	usd
	cvm	Assets Purchased Under Finance Leases AssetsPurchasedUnderFinanceLeases	0	usd
	cvm	Assets Purchased Under Finance Leases AssetsPurchasedUnderFinanceLeases	32409	usd
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	58172	usd
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	28560	usd
	cvm	Accrued Consulting Services To Be Paid With Common Stock AccruedConsultingServicesToBePaidWithCommonStock	110000	usd
	cvm	Accrued Consulting Services To Be Paid With Common Stock AccruedConsultingServicesToBePaidWithCommonStock	110000	usd
	us-gaap	Interest Paid Net InterestPaidNet	809495	usd
	us-gaap	Interest Paid Net InterestPaidNet	872023	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1722750	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13383	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13614	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	794117	shares
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.70
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1200000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	119117	shares
CY2023Q2	cvm	Proceeds From Issuance Of Additional Common Stock Shares ProceedsFromIssuanceOfAdditionalCommonStockShares	190000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	138400	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1975250	shares
	cvm	Stock Issued During Period Share Stock Options Exercised StockIssuedDuringPeriodShareStockOptionsExercised	6500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	179832	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20166	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	58787	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13614	shares
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4976338	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	9102774	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	473723	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	603147	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1540219	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2447772	usd
CY2023Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	188001	usd
CY2022Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	200877	usd
CY2023Q2	cvm	Fair Value Of Series Zwarrants FairValueOfSeriesZwarrants	0	usd
CY2022Q2	cvm	Fair Value Of Series Zwarrants FairValueOfSeriesZwarrants	64787	usd
CY2023Q2	cvm	Fair Value Of Series Aa Warrants FairValueOfSeriesAaWarrants	0	usd
CY2022Q2	cvm	Fair Value Of Series Aa Warrants FairValueOfSeriesAaWarrants	276035	usd
CY2023Q2	cvm	Fair Value Of Series Cc Warrants FairValueOfSeriesCcWarrants	0	usd
CY2022Q2	cvm	Fair Value Of Series Cc Warrants FairValueOfSeriesCcWarrants	24372	usd
CY2023Q2	cvm	Fair Value Of Series Hh Warrants FairValueOfSeriesHhWarrants	0	usd
CY2022Q2	cvm	Fair Value Of Series Hh Warrants FairValueOfSeriesHhWarrants	1597	usd
	cvm	Gain Loss On Derivative Instruments Net Pretax1 GainLossOnDerivativeInstrumentsNetPretax1	0	usd
	cvm	Gain Loss On Derivative Instruments Net Pretax1 GainLossOnDerivativeInstrumentsNetPretax1	366791	usd
	cvm	Incremental Cost Deemed Dividend IncrementalCostDeemedDividend	294000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	437380	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	70589	usd
	cvm	Fair Value Measured On Recurring Basis Gain Loss Included Earnings FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings	0	usd
	cvm	Fair Value Measured On Recurring Basis Gain Loss Included Earnings FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings	-366791	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	35700000	usd
	cvm	Net Of Discount NetOfDiscount	11800000	usd
CY2023Q2	cvm	Finance Lease Liability Payments Due Remainder Of Year FinanceLeaseLiabilityPaymentsDueRemainderOfYear	646000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2655000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2741000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2832000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	2923000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	3015000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	252000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	15064000	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2939000	usd
CY2023Q2	cvm	Net Present Value Of Lease Finance Lease Obligations NetPresentValueOfLeaseFinanceLeaseObligations	12125000	usd
	cvm	Increase In Right Of Use Asset And Liability IncreaseInRightOfUseAssetAndLiability	1100000	usd
CY2023Q2	cvm	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	1700000	usd
CY2022Q3	cvm	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	1900000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1900000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2000000.0	usd
CY2023Q2	cvm	Current Portion Of Operating Lease Obligation CurrentPortionOfOperatingLeaseObligation	200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.102	pure
	cvm	Weighted Average Time To Maturity WeightedAverageTimeToMaturity	P7Y11M8D
CY2023Q2	cvm	Lessee Operating Lease Liability Payments Due Remainder Of Year LesseeOperatingLeaseLiabilityPaymentsDueRemainderOfYear	88000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	357000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	366000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	287000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	277000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	285000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1040000	usd
CY2023Q2	cvm	Lessee Operating Lease Liability Payments LesseeOperatingLeaseLiabilityPayments	2700000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	804000	usd
CY2023Q2	cvm	Cfgh cfgh	1896000	usd
	cvm	Patent Impairment Charges PatentImpairmentCharges	0	usd
	cvm	Patent Impairment Charges PatentImpairmentCharges	31000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	30000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	28000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	24000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	21000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	17000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	54000	usd
CY2023Q2	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	183000	usd
	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-24735151	usd
	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-28533091	usd
CY2023Q2	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-8367281	usd
CY2022Q2	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-9926993	usd
	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	43761395	shares
	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	43124972	shares
CY2023Q2	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	44254363	shares
CY2022Q2	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	43174775	shares
	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.57
	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.66
CY2023Q2	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.19
CY2022Q2	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.23
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13971615	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14446751	shares

Files In Submission

Name	View Source	Status
0001654954-23-010485-index-headers.html	Edgar Link	pending
0001654954-23-010485-index.html	Edgar Link	pending
0001654954-23-010485.txt	Edgar Link	pending
0001654954-23-010485-xbrl.zip	Edgar Link	pending
cvm-20230630.xsd	Edgar Link	pending
cvm_10q.htm	Edgar Link	pending
cvm_ex311.htm	Edgar Link	pending
cvm_ex312.htm	Edgar Link	pending
cvm_ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
cvm-20230630_cal.xml	Edgar Link	unprocessable
cvm-20230630_def.xml	Edgar Link	unprocessable
cvm-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cvm_10q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cvm-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVM
CEL SCI CORP Stock $cvm

2023 Q3 Form 10-Q Financial Statement

#000165495423010485 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM CEL SCI CORP Stock $cvm

2023 Q3 Form 10-Q Financial Statement

#000165495423010485 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM
CEL SCI CORP Stock $cvm